PRPO Stock Analysis: Buy, Sell, or Hold?
PRPO - Precipio, Inc. Common Stock
$24.95
-1.09 (-4.21%)
▼
5d:
-12.37%
30d:
-11.86%
90d:
+6.15%
WAIT
LOW Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When PRPO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PRPO is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PRPO is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PRPO is currently trading at $24.95, which is considered oversold relative to its 30-day fair value range of $27.19 to $30.52.
Technical Outlook: Technically, PRPO is in a uptrend. The price is currently testing key support at $24.61. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $19.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRPO is in a uptrend. The price is currently testing key support at $24.61. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $19.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$27.19 -
$30.52
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.2%)
- BEARISH: Trading 23.8% above Wall St target ($19.00)
- WARNING: Recommendation downgraded due to -12.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$27.19 -
$30.52
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$24.61
Resistance Level
$33.63
Current Trend
Uptrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.43
Wall Street Target
$19.00
(-23.8%)
Revenue Growth (YoY)
22.9%
Profit Margin
-1.5%
Share & Embed Analysis
Last updated: May 18, 2026 5:22 PM ET
Data refreshes hourly during market hours. Next update: 6:22 PM
Data refreshes hourly during market hours. Next update: 6:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRPO showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ahmed Zaki Sabet
BUY
19 shares
2026-04-01
Ahmed Zaki Sabet
BUY
20 shares
2026-01-02
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$613 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$248 | 58 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$131 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 53 HOLD |
